People with a history of cardiac arrest could protect themselves from future risk with one simple daily habit. A study at Intermountain Health in Salt Lake City, Utah, discovered that supplementing ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. NEW ORLEANS — A cholesterol-lowering injection ...

Every Thanksgiving, while millions of Americans gather around tables laden with turkey and pie, emergency rooms brace for an invisible surge: a wave of cardiac emergencies that makes the holiday ...

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor Therapeutics is one step closer to bringing a speedy new weapon to the race against ...

Intermountain Health researchers discovered that customizing vitamin D3 doses for heart attack survivors slashed their risk of another heart attack by 50%. The strategy involved frequent monitoring ...

A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review. The review examined the effects of low doses of ...

Read full article: 🍂 Rake it or leave it? Here’s why you may just want to leave your leaves where they fall Every Thanksgiving, while millions of Americans gather around tables laden with turkey and ...

In a new study, heart attack survivors who received a high, personalized dose of daily vitamin D had a 52 percent lower risk of a repeat heart attack. The results suggest specific vitamin D dosing, ...

Please provide your email address to receive an email when new articles are posted on . Targeted vitamin D supplementation did not reduce major adverse cardiovascular events in patients with a prior ...

Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future ...

A deep clean at the dentist may benefit more than just your oral health. In a two-year study of people with periodontitis or severe gum disease, researchers from University College London (UCL) found ...

A major global trial shows that starting evolocumab early, before a first heart attack or stroke, lowers cardiovascular risk and strengthens the case for aggressive LDL cholesterol reduction in ...